Atlas Venture Fund XI, L.P. - Sep 19, 2022 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
10%+ Owner
Signature
Atlas Venture Fund XI, LP, By: Atlas Venture Associates XI, L.P., it's general partner, By: Atlas Venture Associates XI, LLC, its general partner, By: Ommer Chohan, Chief Financial Officer, /s/ Ommer Chohan
Stock symbol
DAWN
Transactions as of
Sep 19, 2022
Transactions value $
$0
Form type
4
Date filed
9/21/2022, 04:58 PM
Previous filing
Sep 14, 2022
Next filing
Dec 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Other $0 -601K -8.33% $0.00 6.61M Sep 19, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund XI, L.P. ("Atlas Venture Fund XI") to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted by Atlas Venture Fund XI pursuant to Rule 10b5-1 on August 19, 2022.